Variant report
Variant | nsv946495 |
---|---|
Chromosome Location | chr1:168646258-168647441 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs539738415 | chr1:168646268-168646269 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs558066545 | chr1:168646275-168646276 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs181658351 | chr1:168646277-168646278 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs116833886 | chr1:168646280-168646281 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs185720245 | chr1:168646302-168646303 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs71557638 | chr1:168646330-168646331 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs574038119 | chr1:168646334-168646335 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs544384029 | chr1:168646336-168646337 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs563488296 | chr1:168646341-168646342 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs575382900 | chr1:168646384-168646385 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs368223204 | chr1:168646407-168646408 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs367858817 | chr1:168646431-168646432 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs190526500 | chr1:168646483-168646484 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs564343801 | chr1:168646554-168646555 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs12085048 | chr1:168646584-168646585 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs183066374 | chr1:168646628-168646629 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs144854399 | chr1:168646665-168646666 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs544139026 | chr1:168646668-168646669 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs74349971 | chr1:168646692-168646693 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs550446952 | chr1:168646703-168646704 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs187933155 | chr1:168646737-168646738 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs35985727 | chr1:168646761-168646762 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs371307354 | chr1:168646767-168646768 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs147510274 | chr1:168646804-168646805 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs190741658 | chr1:168646817-168646818 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs148596331 | chr1:168647053-168647054 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs555687743 | chr1:168647087-168647088 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs11808391 | chr1:168647094-168647095 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs142980127 | chr1:168647127-168647128 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs556411290 | chr1:168647215-168647216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs533161803 | chr1:168647229-168647230 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs374237896 | chr1:168647250-168647251 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs182987033 | chr1:168647292-168647293 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs552753052 | chr1:168647317-168647318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs545985201 | chr1:168647334-168647335 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs56265357 | chr1:168647367-168647368 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs542669682 | chr1:168647394-168647395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Lung cancer | 18438408 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Breast cancer | 21611746 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Cancer | 17060936 | CNVD |
Lung cancer | 16740712 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
Developmental delay | 21147756 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:168642000-168647200 | Weak transcription | Brain Angular Gyrus | brain |
2 | chr1:168643600-168646800 | Weak transcription | Brain Inferior Temporal Lobe | brain |
3 | chr1:168644800-168647400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr1:168646000-168646400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr1:168646000-168646400 | Weak transcription | Brain Substantia Nigra | brain |
6 | chr1:168646400-168647200 | Enhancers | Brain Substantia Nigra | brain |
7 | chr1:168646800-168647000 | Enhancers | Brain Inferior Temporal Lobe | brain |
8 | chr1:168647200-168647400 | Enhancers | Brain Angular Gyrus | brain |